ClinicalTrials.Veeva

Menu

The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers)

K

King's College London

Status

Unknown

Conditions

Covid19

Treatments

Diagnostic Test: COVID-19 PCR Swab
Device: Wearable Medical Device (Empatica E4)
Diagnostic Test: Pulse Oximeter

Study type

Observational

Funder types

Other

Identifiers

NCT04363489
CEDiD Study

Details and patient eligibility

About

This is a prospective observational cohort study of healthcare workers working in high-risk COVID-19 clinical areas, monitoring heart rate, sleep and temperature, correlating with daily self-reported symptoms, oxygen saturations and PCR Swabs. It will provide information about how many healthcare workers develop COVID-19, what their clinical observations and symptoms are.

Full description

During the COVID-19 Pandemic, doctors and other healthcare workers who work in COVID+ wards, intensive care unit and the accident and emergency department are at high risk of developing COVID-19 infection.

In April 2020, 14.6% of doctors were off sick with suspected or confirmed COVID-19 infection. Meanwhile, 17.9% of COVID+ patients are thought to be asymptomatic. Therefore, healthcare workers are also high-risk of spreading infection to patients, colleagues and their families.

This is a prospective observational cohort study that leverages wearable medical device technology and data analytics to develop an algorithm for early detection of COVID-19 infection in healthcare workers.

A total of 60 healthy healthcare workers working within high-risk COVID-19 clinical areas will be asked to wear a wearable medical device that measures their heart rate, skin temperature and sleep during non-working hours. They will take daily swabs for COVID-19 from themselves, measure their oxygen levels daily, and answer a survey of self-reported symptoms daily for the 30 day study period.

These will then be analyzed to develop an algorithm for early detection of COVID-19 in healthcare workers, and help to inform future workforce decisions, to promote welfare and prevent the spread of COVID-19.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Healthy healthcare professionals of any age

Exclusion Criteria

  • Previous PCR/Antibody positive test for COVID-19
  • Not working in high-risk COVID-19 area (ICU, A&E, COVID positive wards)
  • Involved in COVID-19 Vaccine Trial

Trial contacts and locations

1

Loading...

Central trial contact

Kariem El-Boghdadly, FRCA; Alexander Zargaran, MBBS, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems